Please check your internet connection and try again.
# Citral
## Overview
Citral is a mixture of two acyclic monoterpene geometric isomers, geranial (trans-citral) and neral (cis-citral). It is a component of many essential oils, notably lemon oil. Its therapeutic use is limited and primarily investigated in topical formulations.
## Primary Indications
* **Topical Analgesic/Anti-inflammatory:** Investigated for symptomatic relief of mild to moderate pain and inflammation associated with osteoarthritis, particularly in topical preparations. Evidence for efficacy is limited and not widely established.
* **Aromatherapy:** Used for its scent, primarily in perfumes and cosmetics.
## Adult Dosing
* **Topical Formulations:** Dosing is highly dependent on the specific product formulation (e.g., cream, gel, patch) and concentration. For example, some investigational topical products have used concentrations ranging from 1% to 5%. Specific dosing frequency and amount (e.g., grams of cream applied) would be guided by the product's labeling or local protocol, as there are no universally standardized dosing guidelines.
## Pediatric Dosing
* No established or recommended pediatric dosing. Safety and efficacy have not been evaluated.
## Dose Adjustments
* **Renal or Hepatic Impairment:** No specific dose adjustments are established due to limited systemic absorption and lack of formal studies.
## Contraindications
* Hypersensitivity to citral or any component of the formulation.
* Use on broken or irritated skin.
## Adverse Effects
* **Topical:** Localized skin irritation, redness, itching, and allergic contact dermatitis.
* **Systemic:** Generally considered low risk due to minimal systemic absorption from typical topical use.
## Key Drug Interactions
* **Other Topical Products:** Potential for additive local irritation.
* **Fragrance Allergies:** May exacerbate existing fragrance sensitivities.
## Monitoring
* **Topical Use:** Monitor for signs of local skin irritation or allergic reaction.
## Clinical Pearls
* Citral's role in systemic therapy is not established. Its primary use is limited to topical applications, often in combination with other agents or as a fragrance component.
* Efficacy data for citral as a standalone analgesic or anti-inflammatory agent is not robust.
***
**Disclaimer:** This information is intended for healthcare professionals. Always consult the current prescribing information and relevant literature for complete details before making clinical decisions. Dosing and recommendations may vary based on patient-specific factors and local institutional guidelines.